ES2086733T3 - Procedimiento para acondicionar sustancias solubles en agua. - Google Patents

Procedimiento para acondicionar sustancias solubles en agua.

Info

Publication number
ES2086733T3
ES2086733T3 ES92907877T ES92907877T ES2086733T3 ES 2086733 T3 ES2086733 T3 ES 2086733T3 ES 92907877 T ES92907877 T ES 92907877T ES 92907877 T ES92907877 T ES 92907877T ES 2086733 T3 ES2086733 T3 ES 2086733T3
Authority
ES
Spain
Prior art keywords
procedure
water soluble
soluble substances
conditioning water
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92907877T
Other languages
English (en)
Inventor
Jan Trofast
Eva Trofast
Katarina Bystrom
Edib Jakupovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2086733(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2086733T3 publication Critical patent/ES2086733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treating Waste Gases (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Hydrogenated Pyridines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCESO PARA PROVEER SUSTANCIAS MICRONIZADAS SOLUBLES EN AGUA, LAS CUALES PUEDEN SER PRODUCIDAS, ALMACENADAS Y USADAS MIENTRAS QUE SE MANTIENEN LAS PROPIEDADES AERODINAMICAS REQUERIDAS PARA LA INHALACION DE TALES SUSTANCIAS, CUYO PROCESO SE REALIZA POR: A) REDUCIENDO, SI ES NECESARIO, EL AGUA RESIDUAL DE LA SUSTANCIA MICRONIZADA SECANDO OPCIONALMENTE A UNA ELEVADA TEMPERATURA Y/O VACIO; B) ACONDICIONANDO DICHA SUSTANCIA MICRONIZADA SECADA CON UN DISOLVENTE; Y C) ELIMINANDO EL DISOLVENTE RESIDUAL ALMACENANDOLO EN UN SITIO SECO TAL COMO VACIO, O DEPURANDOLO CON UN GAS INERTE.
ES92907877T 1991-04-11 1992-03-24 Procedimiento para acondicionar sustancias solubles en agua. Expired - Lifetime ES2086733T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
ES2086733T3 true ES2086733T3 (es) 1996-07-01

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92907877T Expired - Lifetime ES2086733T3 (es) 1991-04-11 1992-03-24 Procedimiento para acondicionar sustancias solubles en agua.
ES95111178T Expired - Lifetime ES2168322T3 (es) 1991-04-11 1992-03-24 Sustancias acondicionadas solubles en agua.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95111178T Expired - Lifetime ES2168322T3 (es) 1991-04-11 1992-03-24 Sustancias acondicionadas solubles en agua.

Country Status (28)

Country Link
US (1) US5562923A (es)
EP (3) EP0680752B1 (es)
JP (2) JP3400999B2 (es)
KR (1) KR100216384B1 (es)
AT (2) ATE208613T1 (es)
AU (1) AU662519B2 (es)
BG (1) BG61474B1 (es)
CA (1) CA2106975C (es)
CZ (1) CZ286936B6 (es)
DE (2) DE69232207T2 (es)
DK (2) DK0680752T3 (es)
EE (1) EE02970B1 (es)
ES (2) ES2086733T3 (es)
FI (1) FI105388B (es)
GR (1) GR3020602T3 (es)
HK (1) HK52497A (es)
HU (1) HU211116B (es)
IE (1) IE921144A1 (es)
IS (1) IS3834A (es)
NO (1) NO311867B1 (es)
PL (1) PL168232B1 (es)
PT (1) PT680752E (es)
RO (1) RO115779B1 (es)
RU (1) RU2112507C1 (es)
SE (1) SE9101090D0 (es)
SG (1) SG43180A1 (es)
SK (1) SK280310B6 (es)
WO (1) WO1992018110A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
EP0812195B1 (en) 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
EP2036544B1 (en) * 1997-03-20 2016-12-28 Merck Sharp & Dohme Corp. Dosage form of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
ATE239447T1 (de) * 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
CA2519779A1 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
PL1820494T3 (pl) * 2003-06-13 2010-07-30 Skendi Finance Ltd Mikrocząstki składające się z estradiolu i cholesterolu
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1675720B1 (en) * 2003-10-17 2011-11-23 E.I. Du Pont De Nemours And Company Adhesion of foil to thermoplastic polymers
JP2007520546A (ja) * 2004-02-03 2007-07-26 ケマジス リミティド モンテルカストナトリウムの安定な非晶質性形態
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2396471T3 (es) * 2007-12-13 2013-02-21 Novartis Ag Procedimiento para reducir la tendencia de una sal de glicopirronio a agregarse durante el almacenamiento
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
CA2839398A1 (en) 2011-06-29 2013-01-03 Bayer Intellectual Property Gmbh Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders
SG11201507286QA (en) * 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
DE69232207D1 (de) 2001-12-20
NO933575L (no) 1993-10-06
CZ211693A3 (en) 1994-04-13
JPH06506454A (ja) 1994-07-21
HK52497A (en) 1997-05-02
CZ286936B6 (cs) 2000-08-16
ES2168322T3 (es) 2002-06-16
HU211116B (en) 1995-10-30
SE9101090D0 (sv) 1991-04-11
EE02970B1 (et) 1997-04-15
RU2112507C1 (ru) 1998-06-10
DE69232207T2 (de) 2002-08-01
HU9302870D0 (en) 1993-12-28
PT680752E (pt) 2002-05-31
JP3400999B2 (ja) 2003-04-28
KR100216384B1 (ko) 1999-08-16
PL168232B1 (pl) 1996-01-31
BG98147A (bg) 1994-12-02
DK0680752T3 (da) 2002-02-25
GR3020602T3 (en) 1996-10-31
FI105388B (fi) 2000-08-15
DK0580648T3 (da) 1996-09-16
IS3834A (is) 1992-10-12
FI934429A (fi) 1993-10-08
NO933575D0 (no) 1993-10-06
SG43180A1 (en) 1997-10-17
CA2106975C (en) 2002-03-19
AU662519B2 (en) 1995-09-07
DE69210601D1 (de) 1996-06-13
US5562923A (en) 1996-10-08
DE69210601T2 (de) 1996-10-02
EP0680752A2 (en) 1995-11-08
BG61474B1 (en) 1997-09-30
CA2106975A1 (en) 1992-10-12
ATE137671T1 (de) 1996-05-15
AU1534792A (en) 1992-11-17
HUT65095A (en) 1994-04-28
FI934429A0 (fi) 1993-10-08
RO115779B1 (ro) 2000-06-30
EP0680752A3 (es) 1995-11-22
EP0508969A1 (en) 1992-10-14
JP2003155228A (ja) 2003-05-27
ATE208613T1 (de) 2001-11-15
EP0580648B1 (en) 1996-05-08
EP0580648A1 (en) 1994-02-02
EP0680752B1 (en) 2001-11-14
IE921144A1 (en) 1992-10-21
NO311867B1 (no) 2002-02-11
SK280310B6 (sk) 1999-11-08
SK108893A3 (en) 1994-03-09
WO1992018110A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
ES2086733T3 (es) Procedimiento para acondicionar sustancias solubles en agua.
ECSP941098A (es) Un procedimiento para preparar el ester 1-acetoxietilico de cefuroxima, altamente puro, en forma sustancialmente amorfa
IT1190357B (it) Procedimento criogenito di rimozione di gas acidi da miscele di gas mediante solventi
AR247020A1 (es) Procedimiento criogenico para el retiro selectivo de gases h2s y c02 desde gas natural o sintesis y para retirarlo desde gas natural o de sintesis y obtener una unica corriente.
KR880002541A (ko) α-인터페론의 적용 제형
ES2046674T3 (es) Procedimiento para la regeneracion de una solucion de lavado de alto punto de ebullicion, que contiene co2 y h2s.
JPS5486606A (en) Aerosol composition for cooling
JPS5260899A (en) Purification method of polyalkylene
ES2090842T3 (es) Catalizador solido de acido fosforico y procedimiento para su preparacion y para su uso.
IT1113373B (it) Derivati del 1,5-dimetilbiciclo(3.2.1.)-ottano,preparazione di questi composti e loro impiego come composti per profumi
JPS5248586A (en) Method for preparating air containing ozone
JPS55105700A (en) S-adenosyl-l-methionine-containing composition and its preparation
JPS51121467A (en) Apparatus for the condensation of solvents and the like
JPS5554021A (en) Recovery of organic solvent from mixed gas of organic solvent and air
JPS52129677A (en) Treatment of gas containing nitrogen oxides
FR2334368A1 (fr) Procede d'isolation, a partir des pepins de raisin, d'une substance a activite anti-inflammatoire, et composition pour la peau, contenant une telle substance
JPS5219347A (en) Method to cool down transport pipe line of low temperature liquefied g as
JPS51111490A (en) Manufacturing of absorbent
JPS53147693A (en) Method of removing organic solvent
GB903657A (en) Fluoaluminates as dielectrics
FH A-150 plastic-equivalent gas
CA522953A (en) Stabilization of high molecular weight organic materials containing inorganic acid-forming elements
JPS5231559A (en) Method of separating and recovering organic solvent component
JPS52146776A (en) Recovery of sovent vapor
JPS528670A (en) Organic solvent vapor degreasing tabk

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580648

Country of ref document: ES